1-[2-(methylsulfonyloxy)ethyl]-2-methoxybenzene | 83605-16-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-[2-(methylsulfonyloxy)ethyl]-2-methoxybenzene
• 英文别名: 2-methoxyphenethyl methanesulfonate；1-(2-methanesulfonyloxyethyl)-2-methoxybenzene；2-(2-methoxyphenyl)ethyl methanesulfonate；1-methoxy-2-(2-methanesulfonyloxy)ethylbenzene；2-(2-methoxyphenyl)ethyl methanesulphonate
• CAS: 83605-16-7
• 化学式: C₁₀H₁₄O₄S
• 分子量: 230.285
• InChiKey: MZEDMUOWJVZMEH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  61
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-[2-(methylsulfonyloxy)ethyl]-2-methoxybenzene 以88%的产率得到1-碘-2-(2-甲氧基苯基)乙烷
  参考文献：
  名称：

  US4729994

  摘要：

  公开号：
• 作为产物：
  描述：

  1-(2-甲氧基苯基)乙醇 以96%的产率得到1-[2-(methylsulfonyloxy)ethyl]-2-methoxybenzene
  参考文献：
  名称：

  US4729994

  摘要：

  公开号：

文献信息

• Novel cyclic amide derivatives
  申请人：——

  公开号：US20030212094A1

  公开（公告）日：2003-11-13

  Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: 1 wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH 2 —, —CO—, —O—, —CH(OR 7 )— or the like wherein R 7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R 1 and R 2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: 2 wherein R 3 , R 4 , R 5 , and R 6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: 3 represents an aromatic heterocyclic ring.

  以下公式（I）表示的新化合物作为sigma受体/结合位点的配体，并包括作为活性成分的药物： 其中X代表烷基、芳基、杂环基或类似基团；Q代表由—CH 2 —、—CO—、—O—、—CH(OR 7 )—或类似基团表示的基团，其中R 7 代表氢原子、烷基或类似基团；n代表从0到5的整数；R 1 和R 2 各自代表氢原子、烷基或类似基团；B代表以下任一基团： 其中R 3 、R 4 、R 5 和R 6 各自代表氢原子、卤素原子、烷氧基或类似基团；m代表1或2；以及： 代表芳香杂环环。
• [EN] NEW ALPHA2 ADRENOCEPTOR AGONISTS<br/>[FR] NOUVEAUX AGONISTES DU RÉCEPTEUR ADRÉNERGIQUE ALPHA2
  申请人：ORION CORP

  公开号：WO2013150173A1

  公开（公告）日：2013-10-10

  Compounds of formula (I), wherein X and R1-R6, are as defined in the claims, exhibit alpha2 agonistic activity and thus useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.

  式(I)的化合物，其中X和R1-R6如权利要求中所定义，具有α2激动活性，因此可用作α2激动剂，特别是作为α2A激动剂。还提供了使用上述化合物的方法。
• Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties
  作者：Bruno S. Huegi、Anton M. Ebnoether、Erwin Rissi、Fulvio Gadient、Daniel Hauser、Dietmar Roemer、Heinz H. Buescher、Trevor J. Petcher

  DOI：10.1021/jm00355a010

  日期：1983.1

  activity. Several of these analogues show analgesic potency comparable to morphine in the mouse writhing and tail-flick tests. A number of compounds exhibit high affinity for [3H]naloxone binding sites in rat brain membranes. Among the most potent derivatives are compounds 15 and 48. Although opiate-like, attempts to modify this activity with various substituents have failed to produce antagonistic properties

  已经合成了一系列的4，4-二取代的哌啶并评估了其止痛活性。这些类似物中的几种在小鼠扭动和甩尾试验中显示出与吗啡相当的镇痛效果。许多化合物对大鼠脑膜中的[3H]纳洛酮结合位点显示出高亲和力。在最有效的衍生物中是化合物15和48。尽管是鸦片样的，但尝试用各种取代基修饰该活性未能产生拮抗作用。这些类似物中的一些在豚鼠5-羟色胺毒性试验中和在小鼠中由DL-5-羟色氨酸诱导的头抽搐模型中也显示出明显的持久性5-羟色胺拮抗作用。
• Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same
  申请人：Gallet Sebastien

  公开号：US20060079677A1

  公开（公告）日：2006-04-13

  A compound of formula (I): wherein: represents benzo or pyrido, optionally fused in the 2-3, 3-4 or 4-5 position to a phenyl, (C 4 -C 8 )cycloalkyl or heterocyclic group, which may be optionally substituted, W represents X—Y or Y—X, wherein: X represents and Y represents oxygen or N—R 3 , n represents zero or an integer from 1 to 6, G, R 1 , R 2 and R 3 are as defined in the description, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful for the treatment of cancerous diseases.

  式(I)的化合物：其中：表示苯并或吡啶，并且可以在2-3、3-4或4-5位置与苯基、(C4-C8)环烷基或杂环基融合，该基团可以选择性地被取代，W表示X—Y或Y—X，其中：X表示，Y表示氧或N—R3，n表示零或1到6之间的整数，G、R1、R2和R3如描述中所定义，其对映体和非对映体异构体，以及其与药用酸或碱形成的可接受的盐，以及含有这些化合物的药物产品，用于治疗癌症性疾病。
• PIPERIDINE COMPOUND AND PEST-CONTROL USE THEREFORE
  申请人：Sumitomo Chemical Company Limited

  公开号：EP2845851A1

  公开（公告）日：2015-03-11

  A piperidine compound represented by the following Formula (1): wherein ring A, ring B, and ring C are the same or differen t and each represent a benzene ring or a nitrogen-containing heteroaromatic ring; W represents a C1-C4 alkylene or alkenylene group; X, Y, and Z are the same o r different and each represent a halogen atom, a C1-C6 alkyl group, a halo C1-C6 alkyl group, a C1-C6 alkoxy group, or a halo C1-C6 alkoxy group; m, n, and p are the same or different and each represent an integer of 0 to 5; when m is greater than or equal two 2, the Xs are t he same or different; when n is greater than or equal to 2, the Ys are the same or different; and when p is greater th an or equal to 2, the Zs are the same or different has an excellent controlling efficacy against pests.

  由以下式（1）表示的一种哌啶化合物：其中环A、环B和环C相同或不同，每个代表苯环或含氮杂环；W代表C1-C4烷基或烯基基团；X、Y和Z相同或不同，每个代表卤素原子、C1-C6烷基、卤代C1-C6烷基、C1-C6烷氧基或卤代C1-C6烷氧基；m、n和p相同或不同，每个代表0到5的整数；当m大于或等于2时，X相同或不同；当n大于或等于2时，Y相同或不同；当p大于或等于2时，Z相同或不同，对害虫具有出色的控制效果。